BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38775628)

  • 1. Testing and Treatment Interventions in Community Settings Key to Controlling a Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Glasgow: A Modeling Study.
    Allen LI; Fraser H; Stone J; McAuley A; Trayner KMA; Metcalfe R; Peters SE; Hutchinson SJ; Vickerman P; Hickman M
    J Infect Dis; 2024 May; ():. PubMed ID: 38775628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of a late-detected outbreak among people who inject drugs. A modeling study.
    Gountas I; Hatzakis A; Nikolopoulos G; Touloumi G; Souliotis K
    Int J Drug Policy; 2021 Feb; 88():103032. PubMed ID: 33212371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the impact of interventions during an outbreak of HIV infection among people who inject drugs in 2012-2013 in Athens, Greece.
    Flountzi E; Lim AG; Vickerman P; Paraskevis D; Psichogiou M; Hatzakis A; Sypsa V
    Drug Alcohol Depend; 2022 May; 234():109396. PubMed ID: 35349919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study.
    Gountas I; Sypsa V; Papatheodoridis G; Paraskevis D; Kalamitsis G; Anagnostou O; Antaraki A; Fotiou A; Hatzakis A
    J Viral Hepat; 2019 Nov; 26(11):1311-1317. PubMed ID: 31322302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak.
    Trayner KMA; Palmateer NE; McAuley A; Metcalfe R; Goldberg DJ; Peters E; Craik J; Gunson RN; Thain D; Carter D; Hutchinson SJ
    Int J Drug Policy; 2021 Oct; 96():103304. PubMed ID: 34325970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study.
    Gountas I; Nikolopoulos G; Touloumi G; Fotiou A; Souliotis K
    PLoS One; 2021; 16(10):e0258267. PubMed ID: 34618836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
    Lanièce Delaunay C; Godin A; Kronfli N; Panagiotoglou D; Cox J; Alary M; Klein MB; Maheu-Giroux M
    Int J Drug Policy; 2021 Oct; 96():103343. PubMed ID: 34215459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014-20).
    Roussos S; Paraskevis D; Psichogiou M; Kostaki EG; Flountzi E; Angelopoulos T; Chaikalis S; Papadopoulou M; Pavlopoulou ID; Malliori M; Hatzitheodorou E; Pylli M; Tsiara C; Paraskeva D; Beloukas A; Kalamitsis G; Hatzakis A; Sypsa V
    Addiction; 2022 Jun; 117(6):1670-1682. PubMed ID: 35072299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China.
    Fang K; Wang HL; Lin Y; Li S; Wu J
    Infect Dis Ther; 2023 Apr; 12(4):1043-1055. PubMed ID: 36894824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.
    Doyle CM; Cox J; Milwid RM; Bitera R; Delaunay CL; Alary M; Lambert G; Tremblay C; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2022 Sep; 25(9):e25994. PubMed ID: 36050916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
    Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
    J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.
    Escudero DJ; Lurie MN; Mayer KH; King M; Galea S; Friedman SR; Marshall BDL
    BMC Public Health; 2017 Jul; 17(1):614. PubMed ID: 28738861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018.
    Furukawa NW; Blau EF; Reau Z; Carlson D; Raney ZD; Johnson TK; Deputy NP; Sami S; McClung RP; Neblett-Fanfair R; de Fijter S; Ingram T; Thoroughman D; Vogel S; Lyss SB
    Clin Infect Dis; 2021 Jun; 72(11):1961-1967. PubMed ID: 32748940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Hospital to the Community: Redesigning the Human Immunodeficiency Virus (HIV) Clinical Service Model to Respond to an Outbreak of HIV Among People Who Inject Drugs.
    Metcalfe R; Ragonnet-Cronin M; Bradley-Stewart A; McAuley A; Stubbs H; Ritchie T; O'Hara R; Trayner K; Glover C; Laverty L; Sills L; Brown K; Gunson R; Campbell J; Milsoevic C; Anderson P; Peters SE
    J Infect Dis; 2020 Sep; 222(Suppl 5):S410-S419. PubMed ID: 32877546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
    Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
    J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
    Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
    Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.
    Lanièce Delaunay C; Klein MB; Godin A; Cox J; Kronfli N; Lebouché B; Doyle C; Maheu-Giroux M
    Int J Drug Policy; 2023 Jun; 116():104026. PubMed ID: 37075626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
    Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.